JP2021526519A5 - - Google Patents

Info

Publication number
JP2021526519A5
JP2021526519A5 JP2020565473A JP2020565473A JP2021526519A5 JP 2021526519 A5 JP2021526519 A5 JP 2021526519A5 JP 2020565473 A JP2020565473 A JP 2020565473A JP 2020565473 A JP2020565473 A JP 2020565473A JP 2021526519 A5 JP2021526519 A5 JP 2021526519A5
Authority
JP
Japan
Prior art keywords
film
film according
weight
api
alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020565473A
Other languages
English (en)
Japanese (ja)
Other versions
JP7419263B2 (ja
JP2021526519A (ja
Filing date
Publication date
Priority claimed from GBGB1808462.4A external-priority patent/GB201808462D0/en
Application filed filed Critical
Publication of JP2021526519A publication Critical patent/JP2021526519A/ja
Publication of JP2021526519A5 publication Critical patent/JP2021526519A5/ja
Priority to JP2024002052A priority Critical patent/JP2024050598A/ja
Application granted granted Critical
Publication of JP7419263B2 publication Critical patent/JP7419263B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020565473A 2018-05-23 2019-05-23 医薬製剤 Active JP7419263B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024002052A JP2024050598A (ja) 2018-05-23 2024-01-10 医薬製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1808462.4 2018-05-23
GBGB1808462.4A GB201808462D0 (en) 2018-05-23 2018-05-23 Pharmaceutical formulation
PCT/EP2019/063376 WO2019224323A1 (en) 2018-05-23 2019-05-23 Pharmaceutical formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002052A Division JP2024050598A (ja) 2018-05-23 2024-01-10 医薬製剤

Publications (3)

Publication Number Publication Date
JP2021526519A JP2021526519A (ja) 2021-10-07
JP2021526519A5 true JP2021526519A5 (enExample) 2022-05-26
JP7419263B2 JP7419263B2 (ja) 2024-01-22

Family

ID=62812324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020565473A Active JP7419263B2 (ja) 2018-05-23 2019-05-23 医薬製剤
JP2024002052A Pending JP2024050598A (ja) 2018-05-23 2024-01-10 医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002052A Pending JP2024050598A (ja) 2018-05-23 2024-01-10 医薬製剤

Country Status (15)

Country Link
US (2) US12005140B2 (enExample)
EP (1) EP3796896B1 (enExample)
JP (2) JP7419263B2 (enExample)
KR (1) KR20210031857A (enExample)
CN (1) CN112236133B (enExample)
AU (1) AU2019274772B2 (enExample)
BR (1) BR112020023741A2 (enExample)
CA (1) CA3098112A1 (enExample)
DK (1) DK3796896T3 (enExample)
FI (1) FI3796896T3 (enExample)
GB (1) GB201808462D0 (enExample)
IL (1) IL278927B2 (enExample)
MA (1) MA52704A (enExample)
MX (1) MX2020012336A (enExample)
WO (1) WO2019224323A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3541362T3 (fi) 2016-11-15 2026-02-05 Klaria Pharma Holding Ab Triptaania käsittävä alginaattikalvo
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
SE544672C2 (en) 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US12414916B2 (en) 2021-06-10 2025-09-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
EP4302750A1 (en) * 2022-07-07 2024-01-10 LTS Lohmann Therapie-Systeme AG Oral thin films comprising adrenaline
EP4302751A1 (en) * 2022-07-07 2024-01-10 LTS Lohmann Therapie-Systeme AG Oral thin films with low water activity
CN115950999B (zh) * 2022-12-21 2024-08-30 武汉嘉诺康医药技术有限公司 一种同时检测重酒石酸去甲肾上腺素中api游离碱与配对有机酸的hplc检测方法
US20260108686A1 (en) 2024-10-21 2026-04-23 Belhaven BioPharma Inc. Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933462A (en) * 1958-12-17 1963-08-08 Simone Marie Antoinette Radouc Improvements in or relating to the treatment of meat
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
WO1998001134A1 (en) 1996-07-10 1998-01-15 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
AU3444297A (en) 1996-07-12 1998-02-09 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
US20040247649A1 (en) 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
MXPA04011808A (es) 2002-05-31 2005-09-12 Univ Mississippi Liberacion transmucosica de canabinoides.
DE10226494A1 (de) 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
GB0217382D0 (en) 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20040096569A1 (en) 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
EP2343045A3 (en) 2003-02-24 2011-09-21 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US20070059346A1 (en) 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
KR20050048056A (ko) 2003-11-18 2005-05-24 (주)케이비피 경구용 소모 필름 조성물
EP1781341A1 (en) 2004-08-20 2007-05-09 The Dial Corporation Methods and apparatus for a low-profile air purifier
JP5607291B2 (ja) 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
WO2006095267A1 (en) 2005-03-10 2006-09-14 Institut Pasteur Compositions for the treatment of tumour pathologies, comprising internalin b (in1b) of listeria monocytogene protein or a fragment thereof
PL1863469T3 (pl) * 2005-03-15 2012-05-31 Animal Ethics Pty Ltd Miejscowa kompozycja przeciwbólowa
TW200800142A (en) 2005-09-09 2008-01-01 Univ Manitoba Fast-disintegrating epinephrine tablets for buccal or sublingual administration
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
IL175338A0 (en) 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
CN101081218A (zh) 2006-06-02 2007-12-05 范敏华 一种口腔速崩膜及其制备方法
TW200816985A (en) 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
KR100855566B1 (ko) 2006-09-12 2008-09-03 (주) 아모젠 경구용 소모성 필름
RU2524150C2 (ru) 2006-09-22 2014-07-27 Ново Нордиск А/С Аналоги инсулина, устойчивые к протеазам
US20080269347A1 (en) 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
WO2008073918A1 (en) * 2006-12-11 2008-06-19 Kempharm, Inc. Non-standard amino acid conjugates of amphetamine and processes for making and using the same
EP3542785A1 (en) 2007-01-31 2019-09-25 Rutgers, The State University of New Jersey Controlled release of actives in skin
US20100215774A1 (en) 2007-02-09 2010-08-26 Todd Maibach Film comprising nitroglycerin
US20090246273A1 (en) 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Ketorolac Sublingual Spray for the Treatment of Pain
WO2009126132A1 (en) 2008-03-31 2009-10-15 Mark Rosenberg Formulations and methods for modulating satiety
MX2011002688A (es) 2008-09-12 2011-04-12 Critical Pharmaceuticals Ltd Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
US8900634B2 (en) 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
WO2010104464A1 (en) * 2009-03-13 2010-09-16 Excellens Tech. Products Aps Oral delivery product
CN101574330A (zh) 2009-06-12 2009-11-11 上海现代药物制剂工程研究中心有限公司 苯甲酸利扎曲普坦膜剂
KR101074271B1 (ko) 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
DK2480197T3 (en) 2009-09-25 2016-01-25 Reddys Lab Ltd Dr Compositions containing triptanforbindelser
DK2493457T3 (en) 2009-10-30 2017-10-02 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
KR101077468B1 (ko) * 2011-03-04 2011-11-07 (주)차바이오앤디오스텍 안정한 경구용 속용 필름 제제
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
WO2013019187A1 (en) * 2011-07-29 2013-02-07 Kempharm, Inc. Homoarginine prodrugs and/or conjugates of amphetamine and other stimulants and processes for making and using the same
CA2850964C (en) 2011-10-05 2021-02-02 Jennifer L. Sanders Methods and compositions for treating foot or hand pain
CA2853084C (en) 2011-10-21 2022-04-26 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
SMT201900220T1 (it) * 2012-03-27 2019-07-11 Nicoccino Ab Formulazione di nicotina
WO2013171146A1 (en) 2012-05-15 2013-11-21 Lts Lohmann Therapie-Systeme Ag Oral film containing enteric release opiate resinate
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
FR2994844B1 (fr) 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
CN102871984B (zh) 2012-11-05 2015-11-11 天津市聚星康华医药科技有限公司 一种盐酸去氧肾上腺素口腔速溶膜及其制备方法
CN102961365B (zh) * 2012-12-17 2016-01-20 天津市聚星康华医药科技有限公司 硫酸特布他林口腔速溶膜及其制备方法
KR101643572B1 (ko) * 2013-03-07 2016-07-29 에스케이케미칼주식회사 고함량의 약물을 함유하는 구강 붕해 필름 및 이의 제조방법
WO2014160404A1 (en) 2013-03-13 2014-10-02 The Regents Of The University Of California Improved oral drug devices and drug formulations
US9433589B2 (en) * 2013-06-17 2016-09-06 Rigshospitalet Injectable pharmaceutical compositions comprising adrenaline and citric acid
DE202013105715U1 (de) 2013-08-22 2014-02-19 Sipnose Ltd. Vorrichtung zur Abgabe einer vorbestimmten Menge einer Substanz an eine natürliche Öffnung des Körpers
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
EP3071189A1 (en) * 2013-11-19 2016-09-28 Rigshospitalet Injectable pharmaceutical compositions comprising iloprost
CA2875384A1 (en) 2013-12-20 2015-06-20 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
CA2945818C (en) 2014-04-15 2022-05-03 Vizuri Health Sciences Llc Topical compositions comprising a capsaicinoid for pain relief, manufacture and use
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
AU2015277272A1 (en) 2014-06-16 2017-01-12 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
US10307397B2 (en) 2014-07-28 2019-06-04 Concept Matrix Solutions Oral dissolvable film that includes plant extract
US20170165315A1 (en) 2014-07-31 2017-06-15 Pharmathen S.A. Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
EP3179984A1 (en) 2014-08-14 2017-06-21 Helmholtz-Zentrum für Infektionsforschung GmbH Methods and compositions of carrier systems for the purpose of intracellular drug targeting
CN105878171A (zh) 2014-12-22 2016-08-24 南京海恒医药科技有限公司 一种依达拉奉新制剂及其制备方法
US10335398B2 (en) 2015-04-08 2019-07-02 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granisetron
EP3307280B1 (en) 2015-06-11 2021-10-27 Rejoy Treatment of sexual dysfunction
CN107847469A (zh) 2015-06-27 2018-03-27 美国神农制药责任有限公司 氯胺酮透皮递送系统
US10898537B2 (en) 2015-07-31 2021-01-26 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
US20170079907A1 (en) 2015-09-18 2017-03-23 Insys Development Company, Inc. Sublingual Epinephrine Spray
US10039710B2 (en) 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9833461B2 (en) 2015-10-23 2017-12-05 Ctt Pharma Inc. Therapeutic compositions comprising cannabidiol and corticosteroids
MX393613B (es) 2016-01-07 2025-03-24 Viramal Ltd Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
CN108883308A (zh) 2016-01-26 2018-11-23 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
JPWO2017135195A1 (ja) * 2016-02-03 2018-11-22 社会医療法人蘇西厚生会 まつなみリサーチパーク アレルギー症状の予防又は治療剤
WO2017180707A1 (en) 2016-04-12 2017-10-19 Schaneville Scott Ingestible films having substances from hemp or cannabis
BR112018072467A2 (pt) 2016-05-05 2019-02-19 Aquestive Therapeutics, Inc. composições farmacêuticas com permeação aumentada
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US20180125977A1 (en) 2016-05-05 2018-05-10 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US12427121B2 (en) * 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
WO2017218918A1 (en) * 2016-06-17 2017-12-21 Ys Pharmtech Stabilization of epinephrine formulations
FI3541362T3 (fi) 2016-11-15 2026-02-05 Klaria Pharma Holding Ab Triptaania käsittävä alginaattikalvo
CN107080745A (zh) 2017-04-14 2017-08-22 宁夏医科大学 一种载叶黄素白蛋白纳米粒的口腔速溶膜及其制备方法
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201807942D0 (en) 2018-05-16 2018-06-27 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201911715D0 (en) 2019-08-15 2019-10-02 Klaria Pharma Holding Ab Film formulation comprising carriers
GB201912505D0 (en) 2019-08-30 2019-10-16 Klaria Pharma Holding Ab Pharmaceutical formulation
JP7664916B2 (ja) 2019-11-04 2025-04-18 ビオタ リミテッド 難水溶性の有効成分を含有する経口投与可能なフィルム及びその調製

Similar Documents

Publication Publication Date Title
JP2021526519A5 (enExample)
AU2018380864B2 (en) Oral thin film with high active agent loading
FI3796896T3 (fi) Adrenaliinin farmaseuttinen formulaatio
JP5715400B2 (ja) ロキソプロフェン含有医薬組成物
AU2018420535B2 (en) Edaravone pharmaceutical composition
KR20110065417A (ko) 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
JP2008521827A5 (enExample)
RU2767436C2 (ru) Фармацевтическая композиция
RU2019139286A (ru) Фармацевтический состав
JP2020500220A5 (enExample)
US6297240B1 (en) Method for treating ophthalmic disease through fast dispersing dosage forms
WO2011050728A1 (zh) 一种稳定的雷沙吉兰组合物
US6462094B1 (en) Decongestant/expectorant compositions
JP2012510985A5 (enExample)
JP2025508656A5 (enExample)
CN103153297A (zh) 类萜类似物及其用于治疗神经病症的用途
JP2019534296A5 (enExample)
JP2001081048A (ja) 眼圧降下剤
RU2020138529A (ru) Фармацевтическая композиция
JPH02233613A (ja) ピペリジノアルカノール誘導体類用の液体製剤組成物
US2691679A (en) Therapeutic compounds
TW202114716A (zh) 含有對硼苯基丙胺酸之注射液劑之防止析出方法
FI4081187T3 (fi) Ibuprofeenia ja fenyyliefriiniä käsittävä nestemäinen koostumus
JP6116675B2 (ja) (1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミンおよびサリチル酸成分を含む医薬組成物
JP5299449B2 (ja) 外用剤組成物